Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Rumi, Sumida"'
Autor:
Rumi, Sumida, Hiroshi, Imamura, Setsuko, Anami, Natsuko, Takada, Yuuko, Fujita, Yukie, Inui, Chihiro, Iseki, Keiko, Hamaguchi, Emiko, Yamamoto, Chika, Fujii, Misako, Fujino, Shunji, Kamigaki, Tomono, Kishimoto, Ryouhei, Kawabata, Hiroshi, Furukawa
Publikováno v:
Gan to kagaku ryoho. Cancerchemotherapy. 38(6)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::0ce96cce6763623596a55a6bb34d54a9
https://pubmed.ncbi.nlm.nih.gov/28676600
https://pubmed.ncbi.nlm.nih.gov/28676600
Autor:
Chika, Fujii, Hiroshi, Imamura, Tomono, Kawase, Ryohei, Kawabata, Misako, Fujino, Rumi, Sumida, Chihiro, Iseki, Yoshimi, Hachino, Hiroshi, Furukawa
Publikováno v:
Gan to kagaku ryoho. Cancerchemotherapy. 39(12)
S-1+cisplatin (CDDP) combination therapy is a standard regimen for advanced gastric cancer and is usually administered within the hospital environment. Recently, ambulatory chemotherapy has been applied to treat various cancers. For the realization o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::191da5b2b0507099e09c4cc2622987ab
https://pubmed.ncbi.nlm.nih.gov/23268062
https://pubmed.ncbi.nlm.nih.gov/23268062
Autor:
Misako, Fujino, Chika, Fujii, Hiroshi, Imamura, Tomono, Kishimoto, Ryohei, Kawabata, Rumi, Sumida, Setsuko, Anami, Yoshimi, Hachino, Hiroshi, Furukawa
Publikováno v:
Gan to kagaku ryoho. Cancerchemotherapy. 39(1)
The S-1(tegafur/gimeracil/oteracil potassium)granule was developed to meet the needs of patients with cancer. Although the choice of the patients was thought to spread by the addition of the new agent type, the recognition of the S-1 granule is still
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::303052c4873e49513cab57a879fcf711
https://pubmed.ncbi.nlm.nih.gov/22241359
https://pubmed.ncbi.nlm.nih.gov/22241359
Autor:
Ryohei, Kawabata, Hiroshi, Imamura, Tomono, Kishimoto, Setsuko, Anami, Yukako, Yasui, Misako, Fujino, Chika, Fujii, Rumi, Sumida, Hiroshi, Furukawa
Publikováno v:
Gan to kagaku ryoho. Cancerchemotherapy. 38(5)
Next to ACTS-GC (Adjuvant Chemotherapy Trial of S-1 for Gastric Cancer), adjuvant chemotherapy with S-1 is the standard treatment for stage II or III gastric cancer patients.In this study, we retrospectively examined the continuity and adverse reacti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::bc8e92f1fd41616783a39608ab256763
https://pubmed.ncbi.nlm.nih.gov/21566439
https://pubmed.ncbi.nlm.nih.gov/21566439